Day: August 12, 2022

FOSTER CITY, Calif., Aug. 12, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and non-alcoholic steatohepatitis (NASH), today announced that it has agreed to sell, by way of an underwritten public offering, 12,250,000 shares of its common stock at a price of $2.42 per share and, to certain investors in lieu of common stock, pre-funded warrants to purchase 14,630,000 shares of common stock at a price of $2.4199 per pre-funded warrant, for expected aggregate gross proceeds of approximately $65.0 million, before deducting underwriting discounts and commissions and other offering expenses. The purchase price per share of each pre-funded...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION INTHE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, Aug. 12, 2022 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company”) (TSX: CNT) is pleased to announce that it has filed its condensed consolidated interim financial statements for the first fiscal quarter ended June 30, 2022 and the related management discussion and analysis (“MD&A”). Copies of these documents are available under Century’s SEDAR profile at www.sedar.com and will also be posted on Century’s website at www.centuryglobal.ca. As of June 30, 2022, the Company had strong net working capital1 of $10.2 million, consisting of cash, bank deposits and marketable securities totaling $8.2 million, together with accounts receivables and other current assets of $4.5 million, less accounts payable...

Patent extends protection for SciSparc’s novel compounds and methods already granted in the U.S., Australia and Japan TEL AVIV, Israel, Aug. 12, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system (the “Company” or “SciSparc”), today announced it has been granted an Israeli patent for its core technology that treats central nervous systems disorders. The invention relates to “Pharmaceutical compositions comprising cannabinoids and N-acylethanolamines, and methods for their use in preventing and treating a variety of cannabinoid-treatable conditions.” “Our IP portfolio continues to grow, and it is one of our greatest and most important assets which distinguishes us from other...

Nokia CorporationManagers’ transactions12 August 2022 at 14:30 EEST Nokia Corporation – Managers’ transactions (Batra) Transaction notification under Article 19 of EU Market Abuse Regulation. ____________________________________________Person subject to the notification requirementName: Nishant BatraPosition: Other senior manager Issuer: Nokia CorporationLEI: 549300A0JPRWG1KI7U06Notification type: INITIAL NOTIFICATIONReference number: 18355/7/6____________________________________________ Transaction date: 2022-08-11Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009000681Nature of the transaction: ACQUISITION Transaction details(1): Volume: 1234 Unit price: 5.0645 EUR Aggregated transactions(1): Volume: 1234 Volume weighted average price: 5.0645 EUR About NokiaAt Nokia, we create technology that helps the world...

Basic data about the Company UAB “Orkela” (hereinafter – the Company) is a closed joint-stock company, registered in VĮ “Registrų centras” in 2015. September 24 The Company’s main activity is real estate development and construction. The company owns a plot of land and a complex of buildings located on Vasario 16-osios g. 1, Vilnius. Office address: Jogailos st. 4, Vilnius. The company has no branches or representative offices. The Company’s main activity is real estate development and construction. The company is developing a complex of lyceum and short-term accommodation facilities near Vilnius St. Church and Monastery of Apostles Philip and James. The Company is expected to complete the project in 2023. Highlights of 2022 events of the first half of the year ■ In January and June 2022, the Company...